Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
All content for World Heart Podcasts is the property of World Heart Federation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
Global Heart Podcast: Field Lessons from Ethiopia - Real World Insights in Hypertension Care
World Heart Podcasts
33 minutes
3 months ago
Global Heart Podcast: Field Lessons from Ethiopia - Real World Insights in Hypertension Care
Send us a text In this episode, host Pablo Perel speaks with Dr. Girma Dessie and Dr. Andrew Moran about a powerful example of real-world cardiovascular implementation research from Ethiopia. Dr. Dessie presents a recent study investigating why patients enrolled in a hypertension program were missing follow-up visits, despite strong program support and a standardized care model. The discussion covers the challenges of conducting field research in low-resource settings, particularly during the...
World Heart Podcasts
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
